Editorial: chronic DILI and HILI - corticosteroid plus glycyrrhizin as standard therapy?

Aliment Pharmacol Ther. 2022 Jul;56(1):166-167. doi: 10.1111/apt.16943.

Authors

Rolf Teschke^{1

2}, Axel Eickhoff^{1

2}

Affiliations

¹ Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Germany.
² Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/ Main, Frankfurt/Main, Germany.

PMID: 35689326
DOI: 10.1111/apt.16943

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenal Cortex Hormones / adverse effects
Chemical and Drug Induced Liver Injury*
Glycyrrhizic Acid* / therapeutic use
Humans

Substances

Adrenal Cortex Hormones
Glycyrrhizic Acid